KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Delaware

SS1FORSB120 • 2025

AN ACT TO AMEND TITLES 18, 29, AND 31 OF THE DELAWARE CODE RELATING TO HEALTH INSURANCE.

AN ACT TO AMEND TITLES 18, 29, AND 31 OF THE DELAWARE CODE RELATING TO HEALTH INSURANCE.

Healthcare Labor
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Last action
2026-07-01
Official status
Passed By House. Votes: 40 YES 1 ABSENT
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

AN ACT TO AMEND TITLES 18, 29, AND 31 OF THE DELAWARE CODE RELATING TO HEALTH INSURANCE.

AN ACT TO AMEND TITLES 18, 29, AND 31 OF THE DELAWARE CODE RELATING TO HEALTH INSURANCE.

What This Bill Does

  • AN ACT TO AMEND TITLES 18, 29, AND 31 OF THE DELAWARE CODE RELATING TO HEALTH INSURANCE.
  • This Act requires that individual, group, State employee, and public assistance insurance plans provide coverage for biomarker testing, when the test is supported by medical and scientific evidence.
  • The Act applies to all such policies, contracts, or certificates issued, renewed, modified, altered, amended, or reissued after December 31, 2027.
  • This Act is a substitute for and differs from Senate Bill No.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-07-01 Delaware General Assembly

    Passed By House. Votes: 40 YES 1 ABSENT

  2. 2026-06-23 Delaware General Assembly

    Reported Out of Committee (Appropriations) in House with 4 On Its Merits

  3. 2026-06-16 Delaware General Assembly

    Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 2 Favorable, 7 On Its Merits

  4. 2026-06-16 Delaware General Assembly

    Assigned to Appropriations Committee in House

  5. 2026-06-11 Delaware General Assembly

    Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

  6. 2026-06-10 Delaware General Assembly

    Passed By Senate. Votes: 20 YES 1 ABSENT

  7. 2026-06-09 Delaware General Assembly

    Reported Out of Committee (Finance) in Senate with 4 On Its Merits

  8. 2026-04-22 Delaware General Assembly

    Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 6 Favorable

  9. 2026-04-22 Delaware General Assembly

    Assigned to Finance Committee in Senate

  10. 2026-04-13 Delaware General Assembly

    Adopted in lieu of the original bill SB 120, and Assigned to Banking, Business, Insurance & Technology Committee in Senate

Official Summary Text

AN ACT TO AMEND TITLES 18, 29, AND 31 OF THE DELAWARE CODE RELATING TO HEALTH INSURANCE.
This Act requires that individual, group, State employee, and public assistance insurance plans provide coverage for biomarker testing, when the test is supported by medical and scientific evidence. The Act applies to all such policies, contracts, or certificates issued, renewed, modified, altered, amended, or reissued after December 31, 2027.
This Act is a substitute for and differs from Senate Bill No. 120 in that this Act clarifies that it does not prevent a provision restricting coverage to services by a licensed, certified, or carrier-approved provider or facility, restrict the use of utilization management, or require coverage of biomarker testing for screening purposes or coverage of investigatory and experimental biomarker tests. In addition, the Act differs from Senate Bill No. 120 in that it applies to policies, contracts, or certificates issued, renewed, modified, altered, amended, or reissued after December 31, 2027, rather than December 31, 2026.